Adiponectin and colorectal cancer

作者：Otani Kensuke^*; Ishihara Soichiro; Yamaguchi Hironori; Murono Koji; Yasuda Koji; Nishikawa Takeshi; Tanaka Toshiaki; Kiyomatsu Tomomichi; Hata Keisuke; Kawai Kazushige; Nozawa Hiroaki; Watanabe Toshiaki

来源：Surgery Today, 2017, 47(2): 151-158.

DOI：10.1007/s00595-016-1334-4

• Adiponectin
• Colorectal cancer
• Obesity

Colorectal cancer is an obesity-related malignancy. Adiponectin is an adipokine produced exclusively by adipose tissue, and its concentration in the serum is reduced in obesity. A low serum level of adiponectin is associated with an increased risk of various types of malignancies including colorectal cancer. These facts suggest that the epidemiological link between obesity and cancer may have a significant association with adiponectin. Although numerous studies of colorectal cancer have been reported, the results are conflicting about the anti-cancer effect of adiponectin, and how adiponectin affects carcinogenesis or cancer development remains controversial. Because adiponectin has multiple systemic effects and exists as a high serum concentration protein, the main role of adiponectin should be regulation of homeostasis, and it would not likely act as an anti-cancerous hormone. However, as epidemiological evidence shows, a low adiponectin level may be a basic risk factor for colorectal cancer. We speculate that when the colonic epithelium is stimulated or damaged by another carcinogen under the condition of a low adiponectin level, carcinogenesis is promoted and cancer development is facilitated. In this report, we summarize recent findings of the correlation between adiponectin and colorectal cancer and investigate the effect of adiponectin on colorectal cancer.

• 出版日期2017-2